脱氧胸腺嘧啶核苷

tuō yǎnɡ xiōnɡ xiàn mì dìnɡ hé ɡān
  • deoxythymidine
脱氧胸腺嘧啶核苷脱氧胸腺嘧啶核苷
  1. 2)研究了PET药物(脱氧胸腺嘧啶核苷,简称dT)的高分子化及优化了反应条件,在优化条件下羧基可完全被dT酯化,并可同时被环化;

    Secondly it is used as a support of PET medicine ( thymidine , dT ) and optimizes this reaction conditions . In this optimum reaction conditions , the carboxyl could be completely esterified by dT and dT could be completely looped .

  2. 基因工程菌酶法合成抗癌新药6-甲基嘌呤-2′-脱氧核苷氚胸腺嘧啶核苷([3H]TdR)掺入法检测TP40对T24细胞蛋白质合成的抑制作用。

    Enzymatic synthesis of 6-methylpurine-2 ' - deoxyriboside by recombinant purine nucleoside phosphorylase Tritium labeled thymine deoxyriboside ( [ 3H ] TdR ) uptake was measured to observe DNA synthesis .